Authors
Loading...
Preclinical study reveals that sequential PB2 missense mutations step-wise attenuate influenza A in animal models, indicating a viable rational design strategy for live-attenuated vaccines.
Subbarao et al. (1995) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: